Practicing in a COVID-19 World: An Ideal Telehealth Visit

We’ve discussed telehealth visits a few times now because they’ve become increasingly popular and practically essential right now in the midst of COVID-19 and social distancing. This time though, let’s dive a little deeper into actually holding a telehealth visit. Having the right space, equipment and overall approach are important in creating an ideal experience for…

Tags: , ,

Rise of Telehealth: Practicing in a COVID-19 World

During the COVID-19 quarantine period, telehealth visits skyrocketed in many medical fields. More than 60% of medical patients say the pandemic has increased their willingness to try telehealth, according to a Sykes survey. Now that your doors are open once again (or will be soon), in-person visits can start happening as before. But don’t forget…

Tags: , ,

Re-Opening Your Practice in a COVID-19 World

Last time, we talked about incorporating the right social distancing methods into your practice as we continue to live with COVID-19. But there are also other important steps to take when re-opening to ensure the safety of your patients coming for in-office visits. Here are some COVID-19 protocols to follow when re-opening, according to the…

Tags: , ,

Marketing Strategy and Digital Footprint During COVID-19

COVID 19: Conduct a Strategic Review of Your Practice: Marketing Strategy & Digital Footprint If you’ve recently revisited your strategic plan as part of a strategic review of your dermatology practice, this may be the perfect time to revisit your marketing strategy and digital footprint to help you use both more effectively. No matter what…

Tags: , ,

Revisit Your Strategic Plan In Three Steps

COVID 19: Conduct a Strategic Review of Your Practice: Revisit your Strategic Plan When it comes to reopening your practice and determining how best to help your practice adapt to our new normal, a strategic review of your dermatology practice can be tremendously helpful. In particular, as you look to the future, set time aside…

Tags: , ,